Maximize your thought leadership

Avatar Medical and Kyber Secure €3.7 Million to Bring Immersive 3D Imaging to Hospitals

By Advos•
Avatar Medical and Kyber have secured a €3.7 million grant from France 2030 to develop Avatar MediVerse, aiming to make immersive 3D medical imaging accessible throughout the surgical care pathway.
Avatar Medical and Kyber Secure €3.7 Million to Bring Immersive 3D Imaging to Hospitals

Avatar Medical and Kyber announced on October 1, 2026, that they have secured a grant of up to €3.7 million under the French government's France 2030 program to develop Avatar MediVerse, a project designed to make immersive, personalized imaging available wherever clinicians and patients need it.

The grant, awarded under France 2030, supports the development of Avatar MediVerse (MediVerse), which seeks to expand immersive 3D medical imaging beyond dedicated rooms. Currently, interactive 3D anatomy is often confined to specialized spaces, but MediVerse aims to make it accessible wherever it can be useful in the surgical journey. This could significantly enhance surgical planning, patient communication, and intraoperative decision-making.

The project combines the expertise of two French deeptech companies. Avatar Medical, founded in 2020, specializes in 3D medical visualization and visual intelligence for surgery. Its flagship solution, Avatar Medical Vision, instantly transforms CT scans and MRIs into interactive, realistic 3D visualizations without segmentation, providing clinicians with an intuitive way to understand each patient's specific anatomy. Kyber, a commercial spin-off of KLabs—the company hosting the VideoLAN project, creators of VLC—brings know-how in ultra-low latency XR streaming and remote rendering. Together, they aim to enable the same personalized 3D representation of a patient's anatomy to be used throughout the care pathway, from consultation to surgical planning and into the operating room.

This matters because consistent visual information across the surgical journey can improve collaboration among clinicians and enhance patient understanding. By making immersive 3D imaging accessible wherever needed, MediVerse could reduce logistical barriers and bring advanced visualization to more clinical settings. Avatar Medical's technology is FDA-cleared and CE-marked, and the company collaborates with more than 20 hospitals in the United States and Europe. Originating from research at Institut Curie and Institut Pasteur, Avatar Medical has a proven track record in surgical visualization. Kyber's expertise in real-time infrastructures for healthcare ensures that remote rendering and streaming can be delivered with minimal latency, which is critical for clinical use.

The France 2030 program, a national initiative to boost innovation, supports projects like MediVerse that have the potential to transform healthcare delivery. For hospitals and patients, this investment could lead to more widespread adoption of immersive 3D imaging, ultimately improving surgical outcomes and patient engagement. For the medtech industry, the collaboration between Avatar Medical and Kyber exemplifies how combining visualization and streaming technologies can address unmet needs in surgical care.

For more details, the full announcement can be accessed here. Learn more about Kyber at https://kyber.tech and about Avatar Medical at avatarmedical.ai.

Advos

Advos

@advos